Cybin to participate at the 2024 milken institute future of health summit

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that doug drysdale, cybin's chief executive officer, will be speaking at the 2024 milken institute future of health summit on a panel entitled “the next frontier in mental health research.” “we share the.
CYBN Ratings Summary
CYBN Quant Ranking